Humana Inc. (HUM)
Track the next or latest earnings date for Humana Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
finance.yahoo.com · 2 days ago
Eagle Capital Management, an investment management company, released its first quarter 2026 investor letter. A copy of the letter is available to download here. The letter notes that individual stocks and subsectors are now more reactive to sentiments, reducing market efficiency but creating ...
Deutsche Bank upgrades Humana stock rating on earnings outlook By Investing.comwww.investing.com · 3 days ago
The stock currently trades at $310.55, near its 52-week high of $315.35, following a strong 40% surge over the past six months. The firm now values Humana (NYSE:HUM) at 12 times its revised 2028 earnings per share estimate of $36.74, which includes an expected Stars recovery.
Humana (HUM) is Rebounding to a Multi-Year Improvement in Margins and Returns - Insider Monkeyinsidermonkey.com · 2 days ago
Jim Cramer Said Allbirds Management Are "Jokers" & Discussed These 18 Stocks... ... Humana Inc. (NYSE:HUM) Q1 2026 Earnings Call Transcript
Humana Just Ripped 48% in a Month. Is It Outperforming Other Healthcare Stocks Like UnitedHealth and Cigna? - 24/7 Wall St.247wallst.com · 5 days ago
UnitedHealth Group (UNH) gained ... beating earnings expectations with adjusted EPS of $7.79. Humana benefits disproportionately from favorable Medicare Advantage (MA) rate decisions and improved utilization signals because of its concentrated MA exposure, while UnitedHealth’s diversified Optum mix …
Why Humacyte, Inc. (HUMA) Price Target Was Raised Despite Early-Stage Commercializationfinance.yahoo.com · 4 days ago
We recently compiled a list of the 10 Best Penny Stocks Under $1 According to Hedge Funds. Humacyte, Inc. (NASDAQ:HUMA) is among the best penny stocks under $1 according to hedge funds. TheFly reported on May 14 that HUMA saw its price target increased at TD Cowen to $1.50 from $1.00 in a revised ..…
Latest earnings date
Time not specified
Fiscal quarter: Dec/2025
EPS estimate: -$4.01
Revenue estimate: N/A
Market cap: $21.81B
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Feb 11, 2026 | Dec/2025 | Time not specified | -$4.01 | N/A |